Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-of-care testing are major factors driving growth of Helicobacter pylori diagnostics market.
Market Dynamics
Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment.
Key features of the study:
- This report provides in-depth analysis of the Helicobacter pylori diagnostics market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period: 2018 – 2026, considering 2017 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, product recalls, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global helicobacter pylori diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics.
- The global Helicobacter pylori diagnostics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of helicobacter pylori diagnostic tests/devices, research and consulting firms, new entrants, and financial analysts
- Various strategy matrices used in analyzing the Helicobacter pylori diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
- Global Helicobacter Pylori Diagnostics Market, By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- Global Helicobacter Pylori Diagnostics Market, By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- Global Helicobacter Pylori Diagnostics Market, By Region:
- North America Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By Country:
- Latin America Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By Country:
- Germany
- U.K.
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa Helicobacter Pylori Diagnostics Market
- By Test Type:
- Invasive
- Immunoassay
- Rapid Urease Test
- Histology
- Non-invasive
- Stool Antigen Assays
- Serology Tests
- Urea Breath Test
- By End User:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- By country:
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Thermo Fisher Scientific, Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategies
- Bio-Rad Laboratories Inc.
- Diasorin S.P.A.
- Quidel Corporation
- F. Hoffmann-La Roche Ltd. (Ventana Medical Systems, Inc.)
- Meridian Bioscience, Inc.
- Exalenz Bioscience Ltd.
- Abbott Laboratories
- Cardinal Health, Inc.
- Halyard Health, Inc.
Strategies “*” marked represents similar segmentation in other categories in the respective section.
